A
Annette Champion
Researcher at Abbott Laboratories
Publications - 18
Citations - 2190
Annette Champion is an academic researcher from Abbott Laboratories. The author has contributed to research in topics: Coronary artery disease & Blood pressure. The author has an hindex of 14, co-authored 17 publications receiving 2039 citations. Previous affiliations of Annette Champion include University of Chicago.
Papers
More filters
Journal ArticleDOI
Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous?
Franz H. Messerli,Giuseppe Mancia,C. Richard Conti,Ann C. Hewkin,Stuart Kupfer,Annette Champion,R. Kolloch,Athanase Benetos,Carl J. Pepine +8 more
TL;DR: A secondary analysis of data from a large trial of 2 antihypertensive drug regimens in patients with known coronary artery disease found a J-shaped relationship between diastolic blood pressure and all-cause death and myocardial infarction.
Journal ArticleDOI
Obesity Paradox in Patients with Hypertension and Coronary Artery Disease
Seth Uretsky,Franz H. Messerli,Sripal Bangalore,Annette Champion,Rhonda M. Cooper-DeHoff,Qian Zhou,Carl J. Pepine +6 more
TL;DR: In a population with hypertension and coronary artery disease, overweight and obese patients had a decreased rate of primary outcome compared with patients of normal weight, which was driven primarily by a decreased risk of all-cause mortality.
Journal ArticleDOI
Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST)
R. Kolloch,Udo F. Legler,Annette Champion,Rhonda M. Cooper-DeHoff,Eileen M. Handberg,Qian Zhou,Carl J. Pepine +6 more
TL;DR: Among CAD patients with hypertension, RHR predicts adverse outcomes, and on-treatment RHR is more predictive than baseline RHR.
Journal ArticleDOI
Blood Pressure Control and Improved Cardiovascular Outcomes in the International Verapamil SR-Trandolapril Study
Giuseppe Mancia,Franz H. Messerli,George L. Bakris,Qian Zhou,Annette Champion,Carl J. Pepine +5 more
TL;DR: As proportion of visits with BP control increases, there is an associated steep reduction in cardiovascular risk, independent of baseline characteristics and mean on-treatment BP.
Journal ArticleDOI
Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy
Scott J. Denardo,Yan Gong,Wilmer W. Nichols,Franz H. Messerli,Anthony A. Bavry,Rhonda M. Cooper-DeHoff,Eileen M. Handberg,Annette Champion,Carl J. Pepine +8 more
TL;DR: Optimal management of hypertension in very old coronary artery disease patients may involve targeting specific systolic and diastolic blood pressures that are higher and somewhat lower, respectively, compared with other age groups.